Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,171,913
-
Share change
-
+523,446
-
Total reported value
-
$4,992,600
-
Put/Call ratio
-
38%
-
Price per share
-
$2.30
-
Number of holders
-
34
-
Value change
-
-$35,581
-
Number of buys
-
24
-
Number of sells
-
9
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q1 2018
As of 31 Mar 2018,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,171,913 shares.
The largest 10 holders included
Knoll Capital Management, LP, 683 Capital Management, LLC, MACQUARIE GROUP LTD, RAYMOND JAMES & ASSOCIATES, ARK Investment Management LLC, ACADIAN ASSET MANAGEMENT LLC, Virtu Financial LLC, CITADEL ADVISORS LLC, GROUP ONE TRADING, L.P., and ALPS ADVISORS INC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.